Pool Global Partners

Modl.ai delivers game technology that accelerates game development and enhances player engagement around the world.

Prescryptive Health is a digital health company focused on improving the prescription drug market.

Acorn Biolabs is a healthcare technology company that provides access to the future of cell-based medicine through a non-invasive, follicle-based cell collection and cryopreservation service. Acorn Biolabs is cryopreserving people's healthy young cells for use in future regenerative treatments. Acorn Biolabs' services are available to consumers directly through at-home and in-clinic collections and are available across Canada through a network of clinic and pharmacy partners.

Rentlogic is a tech-enabled standards organization that grades every apartment building in New York City (A, B, C, and F) for health and safety. The grades are based on physical inspections and public data from city agencies. Rentlogic’s methodology was developed in collaboration with stakeholders from all facets of the housing sector to be fair, credible and objective.

Tread is a platform for managing construction equipment services. Tread allows contractors, brokers, and operators to interact as if they’re in the same fleet.

Plantiga provides human movement intelligence, a deep insight into health based on the way people move. Its platform is built to optimize health, prevent injury, and monitor recovery by detecting changes in functional movement patterns that the eye cannot see. The company was founded in 2017 and is headquartered in Vancouver, British Columbia.

InnerSpace is a space utilization platform that helps large enterprises make smarter decisions about using corporate real estate. Our powerful technology leverages a company's existing Wi-Fi infrastructure to provide unrivaled, multi-dimensional data without all the cost and effort needed for traditional sensor-based systems.

Oncoustics is creating and deploying advanced AI solutions for low cost, non-invasive surveillance, diagnostics, and treatment monitoring of diseases with high unmet clinical need. Unlike other players in the space, Oncoustics does not do image recognition. Instead, Oncoustics applies AI to raw ultrasound signals from readily available handheld ultrasound devices to rapidly differentiate healthy versus diseased tissues. There's a wealth of information in these raw signals and this approach reveals novel biomarkers that can be aligned with existing standards and categorization systems. Initially targeting liver disease, a $30B global diagnostic market, Oncoustics has filed a Breakthrough Device Designation Request with the FDA for the OnX that detects liver fibrosis and the 510K is underway. Several follow-on liver products are in development. Oncoustics also has clinical data on other organ indications including prostate, kidney, breast and thyroid diseases and cancers.

Miovision is a traffic management platform developer that collects in-house and outsourced traffic data for advanced traffic signal operations. It develops intelligent technology solutions to address the challenges facing today's transportation network and minimize the environmental impacts of inefficient transportation flow. It offers solutions that collect multimodal traffic data and uncover actionable insights, helping municipalities get more out of their road network. It is a company that uses computer vision and ai to help cities streamline traffic management.